Cannapharmarx Stock Today
CPMD Stock | USD 0 0 42.86% |
PerformanceVery Weak
| Odds Of DistressAbout Average
|
CannaPharmaRx is trading at 0.004 as of the 1st of March 2025, a 42.86 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.004. CannaPharmaRx has 46 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 12th of March 2023 and ending today, the 1st of March 2025. Click here to learn more.
CannaPharmaRX, Inc. operates in the cannabis industry in Canada. The company was incorporated in 1998 and is based in Calgary, Canada. Cannapharmarx operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. The company has 257.57 M outstanding shares. More on CannaPharmaRx
Moving against CannaPharmaRx Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
CannaPharmaRx Pink Sheet Highlights
President CEO, Director | Dominick Colvin |
Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
CannaPharmaRx [CPMD] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.83 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CannaPharmaRx's market, we take the total number of its shares issued and multiply it by CannaPharmaRx's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CannaPharmaRx conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 257.57 M outstanding shares.
CannaPharmaRx currently holds about 5.18 K in cash with (2.41 M) of positive cash flow from operations.
Check CannaPharmaRx Probability Of Bankruptcy
Ownership AllocationCannaPharmaRx holds a total of 257.57 Million outstanding shares. Almost 98.88 percent of CannaPharmaRx outstanding shares are held by general public with 1.12 (percent) owned by insiders and only 0.0 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check CannaPharmaRx Ownership Details
CannaPharmaRx Risk Profiles
Mean Deviation | 6.52 | |||
Semi Deviation | 9.9 | |||
Standard Deviation | 15.12 | |||
Variance | 228.59 |
CannaPharmaRx Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in CannaPharmaRx without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
All Next | Launch Module |
Other Information on Investing in CannaPharmaRx Pink Sheet
CannaPharmaRx financial ratios help investors to determine whether CannaPharmaRx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CannaPharmaRx with respect to the benefits of owning CannaPharmaRx security.